Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Vaccine news in 1Q2023.

<< Previous

Bullboard Posts

Next >>

Comment by Rumpl3StiltSkinon Apr 26, 2023 10:49am

125 Views

Post# 35414506

RE:Vaccine news in 1Q2023.

That is interesting, I always thought 1433 was somewhat limited on the virus front. Very good against corona type virii, for instance.

1433 is 100% effective against bacterium though. So I would expect it to offer an 'elegant' alternative to Anti Biotics, some day.

<< Previous

Bullboard Posts

Next >>

Investors eye Australian gold mining projects amid promising developments